Bulletin
Investor Alert

New York Markets Close in:

Pfizer Inc.

NYS: PFE

GO
/marketstate/country/us

Market open

 --Real time quotes

Feb 25, 2021, 12:19 p.m.

PFE
/zigman2/quotes/202877789/composite

$

33.87

Change

+0.12 +0.35%

Volume

Volume 13.75m

Real time quotes

/zigman2/quotes/202877789/composite

Previous close

$ 33.75

$ 33.87

Change

+0.12 +0.35%

Day low

Day high

$33.74

$34.11

Open

52 week low

52 week high

$26.41

$43.08

Open

Annual Financials for Pfizer Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 52.82B52.55B53.65B51.75B41.91B
Cost of Goods Sold (COGS) incl. D&A 15.95B15.78B16.01B14.74B8.69B
COGS excluding D&A 10.2B9.51B9.62B8.73B8.69B
Depreciation & Amortization Expense 5.76B6.27B6.38B6.01B-
Depreciation 1.7B1.51B1.49B1.4B-
Amortization of Intangibles 4.06B4.76B4.89B4.61B3.44B
Gross Income 36.87B36.77B37.64B37.01B33.22B
20162017201820192020 5-year trend
SG&A Expense 22.6B22.38B22.35B22.89B21.02B
Research & Development 7.84B7.65B7.97B8.62B9.41B
Other SG&A 14.76B14.73B14.38B14.27B11.62B
Other Operating Expense ----3.44B
Unusual Expense 6.65B2.24B3.62B4.53B1.99B
EBIT after Unusual Expense 7.62B(2.24B)11.67B9.59B6.77B
Non Operating Income/Expense 1.45B1.04B1.2B9.42B1.8B
Non-Operating Interest Income 470M391M333M226M73M
Equity in Affiliates (Pretax) ---17M298M
Interest Expense 1.19B1.27B1.32B1.57B1.45B
Gross Interest Expense 1.25B1.34B1.39B1.66B1.45B
Interest Capitalized 61M72M73M88M-
Pretax Income 8.35B12.31B11.89B17.68B7.5B
Income Tax 1.12B(9.05B)706M1.38B477M
Income Tax - Current Domestic 290M14.45B(2.36B)(1.94B)-
Income Tax - Current Foreign 1.53B2.71B2.83B2.9B-
Income Tax - Deferred Domestic (525M)(26.16B)792M1.35B-
Income Tax - Deferred Foreign (175M)(42M)(558M)(919M)-
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 7.23B21.35B11.18B16.3B7.02B
Minority Interest Expense 31M47M36M29M36M
Net Income 7.2B21.31B11.14B16.27B6.99B
Extraordinaries & Discontinued Operations 17M2M10M4M2.63B
Extra Items & Gain/Loss Sale Of Assets -3M---
Cumulative Effect - Accounting Chg -----
Discontinued Operations 17M(1M)10M4M2.63B
Net Income After Extraordinaries 7.22B21.31B11.15B16.27B9.62B
Preferred Dividends 1M1M1M1M-
Net Income Available to Common 7.21B21.3B11.15B16.27B9.62B
EPS (Basic) 1.183.571.902.921.73
Basic Shares Outstanding 6.09B5.97B5.87B5.57B5.56B
EPS (Diluted) 1.173.521.872.871.71
Diluted Shares Outstanding 6.16B6.06B5.98B5.68B5.63B
EBITDA 20.03B20.66B21.67B20.13B-
Link to MarketWatch's Slice.